Skip to content
zameds

Amiloride, hydrochlorothiazide, timolol (Servatrin)

Amiloride, hydrochlorothiazide, timolol

Pharmacare limited û woodmead

Registration

Applicant
Pharmacare limited û woodmead
Certificate holder
Aspen (Pty) Ltd
Registrations
1

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Servatrin

EACH TABLET CONTAINS AMILORIDE HYDROCHLORIDE 2,5 mg HYDROCHLOROTHIAZIDE 25 mg TIMOLOL MALEATE 10 mg

2.5mgTabletsV0354V/7.1.3/354Approved 24 October 2018RegisteredNot determinedPIPIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S3: Amiloride

    Consolidated Schedules 06 July 2026, line 3136

  • S3: Hydrochlorothiazide

    Consolidated Schedules 06 July 2026, line 3721

  • S3: Timolol

    Consolidated Schedules 06 July 2026, line 4325

10 of 19 approved products with this ingredient carry S4 on their leaflet.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

SAHPRA documents

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles